MétaCan
Menu
Back to cohort
Record W1963812298 · doi:10.1016/j.nicl.2013.05.007

Multilocus genetic profiling to empower drug trials and predict brain atrophy

2013· article· en· W1963812298 on OpenAlexfundno aff
Omid Kohannim, Xue Hua, Priya Rajagopalan, Derrek P. Hibar, Neda Jahanshad, Joshua D. Grill, Liana G. Apostolova, Arthur W. Toga, Clifford R. Jack, Michael W. Weiner, Paul M. Thompson

Bibliographic record

VenueNeuroImage Clinical · 2013
Typearticle
Languageen
FieldMedicine
TopicAlzheimer's disease research and treatments
Canadian institutionsnot available
FundersNational Institute of General Medical SciencesNational Institute of Biomedical Imaging and BioengineeringCanadian Institutes of Health ResearchUniversity of California, Los AngelesGenentechNational Institutes of HealthEisaiBayer HealthCareNorthern California Institute for Research and EducationU.S. National Library of MedicineTakeda Pharmaceutical CompanyNovartis Pharmaceuticals CorporationSynarcGE HealthcareAlzheimer's Disease Neuroimaging InitiativeCure Alzheimer's FundMeso Scale DiagnosticsSchering-PloughMedpaceF. Hoffmann-La RocheBioClinicaPfizerBiogenAlzheimer's AssociationAmorfix Life SciencesMerckNational Science Foundation Graduate Research Fellowship ProgramEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentAlzheimer's Drug Discovery FoundationGlaxoSmithKlineBristol-Myers SquibbEli Lilly and CompanyAstraZenecaNational Institute on AgingAbbott LaboratoriesServierWyethUniversity of California, San DiegoU.S. Department of Veterans AffairsFoundation for the National Institutes of HealthNational Science Foundation
KeywordsApolipoprotein EAlzheimer's Disease Neuroimaging InitiativeNeuroimagingAtrophyClinical trialOncologyDiseaseSample size determinationGenetic associationMedicineAlzheimer's diseasePsychologyGenotypeBioinformaticsInternal medicineNeuroscienceBiologyGeneticsGeneSingle-nucleotide polymorphism

Abstract

fetched live from OpenAlex

Designers of clinical trials for Alzheimer's disease (AD) and mild cognitive impairment (MCI) are actively considering structural and functional neuroimaging, cerebrospinal fluid and genetic biomarkers to reduce the sample sizes needed to detect therapeutic effects. Genetic pre-selection, however, has been limited to Apolipoprotein E (ApoE). Recently discovered polymorphisms in the CLU, CR1 and PICALM genes are also moderate risk factors for AD; each affects lifetime AD risk by ~ 10-20%. Here, we tested the hypothesis that pre-selecting subjects based on these variants along with ApoE genotype would further boost clinical trial power, relative to considering ApoE alone, using an MRI-derived 2-year atrophy rate as our outcome measure. We ranked subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI) based on their cumulative risk from these four genes. We obtained sample size estimates in cohorts enriched in subjects with greater aggregate genetic risk. Enriching for additional genetic biomarkers reduced the required sample sizes by up to 50%, for MCI trials. Thus, AD drug trial enrichment with multiple genotypes may have potential implications for the timeliness, cost, and power of trials.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.006
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesInsufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.152
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.006
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.100
GPT teacher head0.436
Teacher spread0.336 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations23
Published2013
Admission routes1
Has abstractyes

Explore more

Same venueNeuroImage ClinicalSame topicAlzheimer's disease research and treatmentsFrench-language works237,207